Related Experiment Video
Updated: Nov 21, 2025

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
Published on: November 17, 2015
Gap Junction Liposomes for Efficient Delivery of Chemotherapeutics to Solid Tumors
Andrea N Trementozzi1, Stephanie Hufnagel2, Haiyue Xu2
1Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States.
Abstract:
Chemotherapeutic delivery is limited by inefficient transport across cellular membranes. Here, we harness the cellular gap junction network to release therapeutic cargos directly into the cytosol. Specifically, cell-derived vesicles, termed connectosomes, contain gap junction transmembrane proteins that open a direct passageway to the cellular interior. Connectosomes were previously shown to substantially improve chemotherapeutic delivery in vitro. Here, we test connectosomes in vivo, using a murine breast tumor model. We demonstrate that connectosomes improve chemotherapeutic delivery to cellular targets within tumors by up to 16-fold, compared to conventional drug-loaded liposomes, suggesting an efficient alternative pathway for intracellular delivery.
Insights
Connectosomes, cell-derived vesicles, enhance chemotherapy delivery by opening cellular pathways. This novel approach significantly improves drug transport into tumor cells, offering a promising alternative to traditional methods.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Drug Delivery Systems
Background:
- Chemotherapeutic efficacy is hindered by poor cellular membrane transport.
- Existing drug delivery methods, like liposomes, face limitations in reaching intracellular targets efficiently.
Purpose of the Study:
- To evaluate the *in vivo* efficacy of connectosomes for enhanced chemotherapeutic delivery.
- To assess connectosomes as a novel intracellular drug delivery system in a murine breast tumor model.
Main Methods:
- Utilized cell-derived vesicles (connectosomes) engineered with gap junction proteins.
- Tested connectosomes loaded with chemotherapeutics in a murine breast tumor model.
- Compared connectosome delivery efficiency against conventional drug-loaded liposomes.
Main Results:
- Connectosomes demonstrated a significant improvement in chemotherapeutic delivery to tumor cells.
- Delivery efficiency was enhanced up to 16-fold compared to liposomes *in vivo*.
- Established connectosomes as an effective pathway for direct intracellular drug delivery.
Conclusions:
- Connectosomes represent a novel and highly efficient strategy for intracellular chemotherapeutic delivery.
- Harnessing the gap junction network via connectosomes overcomes cellular transport barriers.
- This approach offers a promising alternative for improving cancer treatment outcomes.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Bioavailability Enhancement: Drug Permeability Enhancement
Gap Junctions
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...

